Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyue Yan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Biomaterials Science|June 11, 2021
Harnessing lipid nanoparticles for efficient CRISPR deliveryJingyue Yan, Diana D Kang, Yizhou Dong
Advanced Drug Delivery Reviews|November 12, 2021
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancerJingyue Yan, Diana D Kang, Gillian Turnbull, et al.
Exploration (Beijing, China)|November 7, 2023
Adoptive cell therapy for cancer treatmentShi Du, Jingyue Yan, Yonger Xue, et al.
Materials (Basel, Switzerland)|August 16, 2017
Influence of N₂ Partial Pressure on Structure and Mechanical Properties of TiAlN/Al₂O₃ MultilayersJingyue Yan, Lei Dong, Chongkuan Gao, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2020
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In VivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Bioactive Materials|March 25, 2020
Long-term storage of lipid-like nanoparticles for mRNA deliveryPengxuan Zhao, Xucheng Hou, Jingyue Yan, et al.
Journal of Biomedical Nanotechnology|September 1, 2018
Glycyrrhetinic Acid Functionalized Nanoparticles for Drug Delivery to Liver CancerFei Wu, Xiaocheng Li, Bin Jiang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Molecular Therapy. Nucleic Acids|February 12, 2020
CRISPR-Cas12a Possesses Unconventional DNase Activity that Can Be Inactivated by Synthetic OligonucleotidesBin Li, Jingyue Yan, Youxi Zhang, et al.
Molecular Cell|August 30, 2023
Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress responseRobert V Swanda, Quanquan Ji, Xincheng Wu, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Biomaterials Science|June 11, 2021
Harnessing lipid nanoparticles for efficient CRISPR deliveryJingyue Yan, Diana D Kang, Yizhou Dong
Advanced Drug Delivery Reviews|November 12, 2021
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancerJingyue Yan, Diana D Kang, Gillian Turnbull, et al.
Exploration (Beijing, China)|November 7, 2023
Adoptive cell therapy for cancer treatmentShi Du, Jingyue Yan, Yonger Xue, et al.
Materials (Basel, Switzerland)|August 16, 2017
Influence of N₂ Partial Pressure on Structure and Mechanical Properties of TiAlN/Al₂O₃ MultilayersJingyue Yan, Lei Dong, Chongkuan Gao, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2020
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In VivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Bioactive Materials|March 25, 2020
Long-term storage of lipid-like nanoparticles for mRNA deliveryPengxuan Zhao, Xucheng Hou, Jingyue Yan, et al.
Journal of Biomedical Nanotechnology|September 1, 2018
Glycyrrhetinic Acid Functionalized Nanoparticles for Drug Delivery to Liver CancerFei Wu, Xiaocheng Li, Bin Jiang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Molecular Therapy. Nucleic Acids|February 12, 2020
CRISPR-Cas12a Possesses Unconventional DNase Activity that Can Be Inactivated by Synthetic OligonucleotidesBin Li, Jingyue Yan, Youxi Zhang, et al.
Molecular Cell|August 30, 2023
Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress responseRobert V Swanda, Quanquan Ji, Xincheng Wu, et al.
Pageof 3